Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rampe

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The American Journal of Physiology|December 1, 1991
Parathyroid hormone: an endogenous modulator of cardiac calcium channelsD Rampe, A E Lacerda, R C Dage, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
High affinity [3H]glibenclamide binding sites in rat neuronal and cardiac tissue: localization and developmental characteristicsJ A Miller, N L Velayo, R C Dage, et al.
Molecular Pharmacology|September 1, 1993
Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heartD Rampe, B Wible, D Fedida, et al.
Molecular Pharmacology|December 23, 2000
Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERGJ Kang, L Wang, X L Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176D Rampe, B Anderson, V Rapien-Pryor, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1987
Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranesD Rampe, E Luchowski, A Rutledge, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channelsY A Kuryshev, A M Brown, L Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channelD Rampe, Z Wang, B Fermini, et al.
Biochemical and Biophysical Research Communications|June 29, 1990
[3H]PN200-110 binding in a fibroblast cell line transformed with the alpha 1 subunit of the skeletal muscle L-type Ca2+ channelD Rampe, H S Kim, A E Lacerda, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 1999
Cardiovascular safety of fexofenadine HClC Pratt, A M Brown, D Rampe, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Physiology|December 1, 1991
Parathyroid hormone: an endogenous modulator of cardiac calcium channelsD Rampe, A E Lacerda, R C Dage, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
High affinity [3H]glibenclamide binding sites in rat neuronal and cardiac tissue: localization and developmental characteristicsJ A Miller, N L Velayo, R C Dage, et al.
Molecular Pharmacology|September 1, 1993
Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heartD Rampe, B Wible, D Fedida, et al.
Molecular Pharmacology|December 23, 2000
Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERGJ Kang, L Wang, X L Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176D Rampe, B Anderson, V Rapien-Pryor, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1987
Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranesD Rampe, E Luchowski, A Rutledge, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channelsY A Kuryshev, A M Brown, L Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channelD Rampe, Z Wang, B Fermini, et al.
Biochemical and Biophysical Research Communications|June 29, 1990
[3H]PN200-110 binding in a fibroblast cell line transformed with the alpha 1 subunit of the skeletal muscle L-type Ca2+ channelD Rampe, H S Kim, A E Lacerda, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 12, 1999
Cardiovascular safety of fexofenadine HClC Pratt, A M Brown, D Rampe, et al.
Pageof 5